(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RANDVIJIAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RANDVIJIAN

ST13

US500000098852363

Class

5

Filing

98852363

Registration

7859450

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

04/03/2026

Trademark type

Word

Nice classes

5

Filing date

11/13/2024

Registration date

07/08/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/08/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

09/05/2024

First use in commerce

09/05/2024

Drawing code

4

Owner type

99

Owner location

Guangzhou, CN

Examiner

CERDA, VICTOR

Law office

N50

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Guangzhou Yuanming Technology Co., Ltd

Representatives

Yipin Zhang

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Dietary food supplements; Dieting pills and powder preparations to promote fat burning; Health food supplements; Medicaments for promoting recovery from tendon and muscle injuries and disorders and sports related injuries; Medicines for intestinal disorders; Mineral nutritional supplements; Nutraceuticals for use as a dietary supplement; Nutritional supplementsprobiotic compositions; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical products for the prevention and treatment of cancer

Publications

History of USPTO decisions and trademark events.

15 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/08/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

07/08/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/20/2025

PUBO

PUBLISHED FOR OPPOSITION

05/20/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/14/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/21/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/20/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/20/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/20/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/18/2025

GNRT

NON-FINAL ACTION E-MAILED

04/18/2025

CNRT

NON-FINAL ACTION WRITTEN

04/18/2025

DOCK

ASSIGNED TO EXAMINER

04/17/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/13/2024

NWAP

NEW APPLICATION ENTERED

11/13/2024

Continuous trademark protection

Get notified about every new filing that threatens RANDVIJIAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.